Variable | General population | No reflow | Absence no reflow | p |
Mean age | 60 (24 - 86) | 63 (24 - 83) | 59 (29 - 86) | 0.03 |
Age > 75 years | 30 (8.4%) | 11 (13%) | 19 (7%) | 0.03 |
Male | 297 (84%) | 70 (82.3%) | 227 (84.4%) | 0.61 |
Diabetes | 115 (34.3%) | 35 (41.2%) | 80 (29.7%) | 0.04 |
Hypertension | 104 (31%) | 34 (40%) | 70 (26%) | 0.01 |
Dyslipidemia | 39 (11%) | 6 (7%) | 33 (12.3%) | 0.19 |
Active smoking | 195 (54.8%) | 44 (51.8%) | 150 (55.8%) | 0.07 |
History of Coronary | 58 (16.4%) | 15 (17.6%) | 43 (16%) | 0.2 |
History of PAC | 15 (4.2%) | 4 (5%) | 11 (4%) | 0.5 |
History of CI | 15 (4.2%) | 4 (5%) | 11 (4%) | 0.5 |
History of stroke | 23 (6.5%) | 5 (5.9%) | 18 (6.7%) | 0.7 |
History of PAD | 24 (6.8%) | 6 (7%) | 18 (6.7%) | 0.9 |
History of FA | 24 (6.8%) | 7 (8%) | 17 (6%) | 0.3 |
Tachycardia | 71 (20%) | 29 (34.1%) | 42 (15.6%) | 0.0001 |
Hypotension | 37 (10.5%) | 19 (22.3%) | 18 (6.7%) | 0.0001 |
LVF admission | 149 (42%) | 58 (68.2%) | 91 (33.8%) | 0.01 |
Killip 1 | 98 (27.6%) | 32 (37.6%) | 66 (24.5%) | - |
Killip 2 | 9 (2.5%) | 2 (2.3%) | 7 (2.6%) | - |
Killip 3 | 7 (1.9%) | 3 (3.5%) | 4 (1.4%) | - |
Killip 4 | 35 (9.8%) | 21 (24.7%) | 14 (5.2%) | 0.0001 |
Hyperglycemia > 11 | 129 (36.4%) | 37 (43.5%) | 92 (34.2%) | 0.005 |
Average CPK peak | 2586 | 2785 | 2515 | 0.4 |
Renal insufficiency | 41 (11.6%) | 15 (17.6%) | 26 (9.6%) | 0.009 |
LV dysfunction | 88 (25%) | 33 (38.8%) | 55 (20.4%) | 0.02 |
MI location | ||||
Anterior | 161 (45.5%) | 41 (48.2%) | 120 (44.6%) | 0.7 |
Inferior | 169 (47.8%) | 36 (42.3%) | 133 (49.4%) | 0.8 |
Lateral | 17 (4.8%) | 7 (8.2%) | 10 (3.7%) | 0.6 |